Bradika-ET Tablet
Prescription Required
Product introduction
Bradika-ET Tablet is a combination of two medicines. It is used in the treatment of pain caused due to nerve damage (neuropathic pain).
Bradika-ET Tablet can be taken with or without food, but it is important to take this medicine at the same time each day to get the most benefit. The exact dose and duration of treatment will depend on your condition and how you respond to it. Your doctor will probably start this medicine at a low dose and increase it gradually. It may take a few weeks for the medicine to work properly. Follow your doctor’s instructions and continue taking it regularly until your doctor advises you to stop. Do not miss any dose, otherwise, your condition may worsen.
The side effects of this medicine are usually mild and go away by themselves. The most common ones are feeling sleepy or dizzy, dryness in the mouth, blurred vision, weight gain, edema (swelling over the whole body), and difficulty in concentrating. Most side effects are not serious and do not need medical attention. Talk to your doctor about potential side effects and ways in which you might prevent or cope with them.
Before taking the medicine you should tell your doctor if you are pregnant, breastfeeding or planning to become pregnant. Be careful while driving as sleepiness, dizziness, and blurring of vision may be seen as side effects. You should avoid drinking alcohol along with this medicine as it may lead to excessive sleepiness and dizziness.
Uses of Bradika-ET Tablet
Benefits of Bradika-ET Tablet
In Neuropathic pain
Bradika-ET Tablet is a combination of medicines used to treat long-lasting (chronic) pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness. Pregabalin, an active ingredient of this medicine, is thought to work by interfering with pain signals that travel through the damaged nerves and the brain. It also improves nerve conduction and enhances the quality of life.
Side effects of Bradika-ET Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Bradika-ET
- Dizziness
- Sleepiness
- Dryness in mouth
- Swelling
- Blurred vision
- Weight gain
- Impaired concentration
- Stomach pain
- Headache
- Fatigue
- Increased appetite
How to use Bradika-ET Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Bradika-ET Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Bradika-ET Tablet works
Bradika-ET Tablet is a combination of two medicines: Pregabalin and Etoricoxib. Pregabalin is an antiepileptic medication and belives to block pain by interfering with pain signals traveling through the damaged nerves and the brain. Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) called COX-2 inhibitors. It works by blocking the release of certain chemical messengers that are responsible for pain and inflammation (redness and swelling).
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Bradika-ET Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Bradika-ET Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Bradika-ET Tablet during breastfeeding is not available. Please consult your doctor.
Driving
CONSULT YOUR DOCTOR
It is not known whether Bradika-ET Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Bradika-ET Tablet in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Bradika-ET Tablet in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Bradika-ET Tablet
₹27.2/Tablet
Nucoxia PG 75mg/60mg Tablet
Zydus Cadila
₹27.3/tablet
same price
Ebov PG 75mg/60mg Tablet
Glenmark Pharmaceuticals Ltd
₹27.6/tablet
1% costlier
Etoxizip PG 75mg/60mg Tablet
Elisa Biotech Pvt Ltd
₹20.2/tablet
26% cheaper
Neroqin-ET 75mg/60mg Tablet
Mysticism Healthcare
₹26.9/tablet
1% cheaper
Paineura ET 75mg/60mg Tablet
Ulterius Pharmaceuticals Private Limited
₹19.5/tablet
28% cheaper
Quick tips
- Bradika-ET Tablet should be taken as per the dose and duration prescribed by your doctor.
- Do not skip any dose and finish the complete course even if you feel better.
- It may cause sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- It may cause blurring or loss of vision. Inform your doctor immediately if you notice any vision changes.
- During long-term treatment, your doctor may want to take regular blood tests to monitor your liver function.
- Bradika-ET Tablet should be taken as per the dose and duration prescribed by your doctor.
- Do not skip any dose and finish the complete course even if you feel better.
- It may cause sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- It may cause blurring or loss of vision. Inform your doctor immediately if you notice any vision changes.
- During long-term treatment, your doctor may want to take regular blood tests to monitor your liver function.
Fact Box
Habit Forming
No
Therapeutic Class
NEURO CNS
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Pregabalin. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 557-60.
- McNamara JO. Pharmacotherapy of the Epilepsies. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 599.
- Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 992.
Marketer details
Name: Elaptus India
Address: SCO: 540, 1st Floor, Kesho Ram Complex, Sector 45-C,Burail, Chandigarh-160047
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present
